Physician

Clay Matthew Barbin, M.D.

According to 2025 Medicare claims, Clay Barbin, M.D. (NPI: 1659715696) practices cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Barbin is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Barbin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,846 traditional Medicare patients, billed 6,584 HCPCS/CPT codes, and received $589,214 in Medicare payments. The top billing code was 99487 (Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month). Part D data shows 8,594 prescription claims across 1,101 beneficiaries totaling $1,657,149 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 44 records totaling $1,649. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $94,281 to $589,214. Similarly, Part D prescription costs have risen steadily, from $7,027 to $1,657,149. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	497	1,334	$94,281
2021	1,369	3,835	$319,757
2022	1,549	4,297	$375,778
2023	1,875	5,278	$480,060
2024	1,846	6,584	$589,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	170	$7,027
2016	37	174	$11,149
2017	34	99	$8,108
2018	35	95	$8,767
2019	125	346	$25,020
2020	164	526	$26,134
2021	395	2,731	$215,892
2022	676	5,055	$705,301
2023	890	6,341	$1,176,988
2024	1,101	8,594	$1,657,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99487	Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month	212	620	$102
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	378	379	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	930	1,237	$86
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	697	765	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	233	260	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	616	24,296	$457,258
Jardiance	Empagliflozin	399	15,969	$306,960
Repatha Sureclick	Evolocumab	170	10,760	$207,241
Farxiga	Dapagliflozin Propanediol	236	9,554	$175,388
Entresto	Sacubitril/Valsartan	179	7,350	$156,124

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,649	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Clay Matthew Barbin, M.D.?

Tedicare shows public-source Medicare data for Clay Matthew Barbin, M.D. (NPI 1659715696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Clay Matthew Barbin, M.D. have ACO affiliation data?

Clay Matthew Barbin, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Clay Matthew Barbin, M.D.?

Clay Matthew Barbin, M.D. is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Clay Matthew Barbin, M.D. have Open Payments data?

Clay Matthew Barbin, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.